Stem Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
400
NCT06485843
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
Phase: Phase 2
Role: Lead Sponsor
Start: May 21, 2025
Completion: Dec 31, 2028
Loading map...